anticoagulation system cosisting two drugs pegnivacogin singlestranded aptamer binds inhibits factor ixa anivamersen complementary sequence reversal control mechanism action involves inhibition factor developed use patients undergoing percutaneous coronary intervention treatment acute coronary associated severe allergic phase radar allergiclike reactions occurred shortly administration pegnivacogin three patients histories allergy one clinical trial found evidence reduced ischaemic events bleeding compared biology article stub help wikipedia expanding